Sabra Healthcare REIT Inc (SBRA) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Sabra Healthcare REIT Inc stock (SBRA) is currently trading at $19.84. Sabra Healthcare REIT Inc PE ratio is 31.00. Sabra Healthcare REIT Inc PS ratio (Price-to-Sales) is 6.45. Analyst consensus price target for SBRA is $21.85. WallStSmart rates SBRA as Hold.
- SBRA PE ratio analysis and historical PE chart
- SBRA PS ratio (Price-to-Sales) history and trend
- SBRA intrinsic value — DCF, Graham Number, EPV models
- SBRA stock price prediction 2025 2026 2027 2028 2029 2030
- SBRA fair value vs current price
- SBRA insider transactions and insider buying
- Is SBRA undervalued or overvalued?
- Sabra Healthcare REIT Inc financial analysis — revenue, earnings, cash flow
- SBRA Piotroski F-Score and Altman Z-Score
- SBRA analyst price target and Smart Rating
Sabra Healthcare REIT Inc
📊 No data available
Try selecting a different time range
SBRA Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Sabra Healthcare REIT Inc (SBRA)
SBRA trades 351% above its Graham fair value of $4.35, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Sabra Healthcare REIT Inc (SBRA) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in operating margin, price/book, profit margin. Concerns around peg ratio and return on equity. Fundamentals are solid but monitor weak areas for improvement.
Sabra Healthcare REIT Inc (SBRA) Key Strengths (5)
Keeps $20 of every $100 in revenue as net profit
105.42% of shares held by major funds and institutions
Strong operational efficiency: $24 kept per $100 revenue
Trading at 1.75x book value, attractively priced
Mid-cap company balancing growth potential with stability
Supporting Valuation Data
Sabra Healthcare REIT Inc (SBRA) Areas to Watch (5)
Earnings declining -44.70%, profits shrinking
Very expensive relative to growth, significant premium
Low profitability relative to shareholder equity
Premium valuation at 6.5x annual revenue
Solid revenue growth at 15.80% per year
Supporting Valuation Data
Sabra Healthcare REIT Inc (SBRA) Detailed Analysis Report
Overall Assessment
This company scores 57/100 in our Smart Analysis, earning a C grade. Out of 10 metrics analyzed, 5 register as strengths (avg 8.6/10) while 5 fall into concern territory (avg 3.0/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Profit Margin, Institutional Own., Operating Margin. Valuation metrics including Price/Book (1.75) suggest the stock is attractively priced. Profitability is solid with Operating Margin at 23.70%, Profit Margin at 20.10%.
The Bear Case
The primary concerns are EPS Growth, PEG Ratio, Return on Equity. Some valuation metrics including PEG Ratio (3.15), Price/Sales (6.45) suggest expensive pricing. Growth concerns include Revenue Growth at 15.80%, EPS Growth at -44.70%, which may limit upside. Profitability pressure is visible in Return on Equity at 5.59%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether EPS Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 5.59% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 15.80% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. Strengths and concerns are roughly balanced. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (Profit Margin, Institutional Own.) and negatives (EPS Growth, PEG Ratio). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
SBRA Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
SBRA's Price-to-Sales ratio of 6.45x trades at a deep discount to its historical average of 66.6x (7th percentile). The current valuation is 99% below its historical high of 534.09x set in Jan 2011, and 52% above its historical low of 4.23x in Mar 2020.
Compare SBRA with Competitors
Top REIT - HEALTHCARE FACILITIES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Sabra Healthcare REIT Inc (SBRA) · REAL ESTATE › REIT - HEALTHCARE FACILITIES
The Big Picture
Sabra Healthcare REIT Inc is a strong growth company balancing expansion with improving profitability. Revenue reached 776M with 16% growth year-over-year. Profit margins are strong at 20.1%, reflecting pricing power and operational efficiency.
Key Findings
Profit margin of 20.1% and operating margin of 23.7% demonstrate strong pricing power and operational efficiency.
Generating 87M in free cash flow and 87M in operating cash flow. Earnings are translating into actual cash generation.
Earnings fell 45% YoY while revenue grew 16%. This gap usually reflects one-time items (tax benefits, write-offs) in the prior period, not an operational decline.
What to Watch Next
Dividend sustainability with a current yield of 6.1%. Watch payout ratio and free cash flow coverage.
Sector dynamics: monitor REIT - HEALTHCARE FACILITIES industry trends, competitive moves, and regulatory changes that could impact Sabra Healthcare REIT Inc.
Bottom Line
Sabra Healthcare REIT Inc offers an attractive blend of growth (16% revenue expansion) and improving fundamentals. The company is transitioning from pure growth to profitable growth, a critical inflection point. Watch for sustained margin expansion as the key signal.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(33 last 3 months)
Data sourced from SEC Form 4 filings
Last updated: 12:57:02 PM
About Sabra Healthcare REIT Inc(SBRA)
NASDAQ
REAL ESTATE
REIT - HEALTHCARE FACILITIES
USA
As of September 30, 2020, Sabra's investment portfolio included 425 real estate properties held for investment (consisting of (i) 287 skilled nursing / transitional care facilities, (ii) 64 senior housing communities (?